Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.
Afya Limited (AFYA) is a Brazil-focused medical education group and medical practice solutions provider whose news flow reflects developments across education, healthcare and capital markets. The company describes itself as a leading medical education group in Brazil based on the number of medical school seats, operating an end‑to‑end physician‑centric ecosystem that spans undergraduate education, continuing medical education and digital tools that support medical practice.
News about Afya often covers its quarterly and interim financial results, where the company reports performance for its three segments: Undergraduate, Continuing Education and Medical Practice Solutions. These updates include information on revenue, adjusted EBITDA, net income and key operational drivers such as approved medical school seats, total students, active payers and users positively impacted by its ecosystem.
Investors following AFYA news will also see announcements related to regulatory and academic milestones in Brazil, such as authorizations from the Ministry of Education (MEC) to increase medical school seats at specific campuses. These decisions affect Afya’s capacity in its Undergraduate segment and are highlighted as important growth drivers in the company’s communications.
Corporate and capital structure events are another recurring theme. Afya has issued commercial notes through its subsidiary Afya Participações S.A., repaid debentures, and entered into agreements to repurchase and cancel Series A perpetual convertible preferred shares previously issued to an affiliate of SoftBank. The board of directors has also approved share repurchase programs for Class A common shares, and the company has reported changes to its board composition and independent registered public accounting firm.
This news page aggregates these types of updates so readers can track AFYA’s financial performance, governance decisions, regulatory developments in medical education and initiatives within its medical practice solutions segment. For investors and observers of Brazil’s education and healthcare sectors, Afya’s news provides ongoing insight into how the company manages its physician‑centric ecosystem and capital structure.
Afya Limited (NASDAQ: AFYA), Brazil's leading medical education and practice solutions provider, has published its 2024 Sustainability Report. The comprehensive report adheres to multiple international reporting frameworks including GRI standards, SASB indicators, and aligns with the Sustainable Development Goals (SDGs).
The report features the company's fifth Greenhouse Gas Emissions Inventory and comprises two parts: a narrative document and a technical Excel annex. Both components have been independently audited by KPMG.
Afya Limited (Nasdaq: AFYA), a Brazilian education company, announced the successful completion of its Annual General Meeting on June 24, 2025. The shareholders approved all resolutions presented, including the ratification of the company's 2024 financial statements and the re-appointment of four independent directors.
The re-appointed directors, each serving a two-year term, are João Paulo Seibel de Faria, Vanessa Claro Lopes, Miguel Filisbino Pereira de Paula, and Marcelo Ken Suhara.
Afya (NASDAQ: AFYA) reported strong financial results for Q4 and full-year 2024. Fourth quarter highlights include:
- Net Revenue up 16.3% YoY to R$849.0 million
- Adjusted EBITDA increased 26.7% YoY to R$366.0 million
- Net Income grew 51.4% YoY to R$154.3 million
Full-year 2024 achievements:
- Net Revenue reached R$3,304.3 million (+14.9% YoY)
- Adjusted EBITDA of R$1,455.6 million (+24.9% YoY)
- Net Income of R$648.9 million (+60.1% YoY)
- Operating Cash Conversion ratio of 102.2%
The company announced its first dividend distribution, with a 20% payout of 2024 net income (R$129.8 million). Afya expanded its medical education footprint through acquisitions and seat additions, reaching 3,653 approved medical school seats. The ecosystem now serves over 313,000 users.
Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group, has announced its first-ever cash dividend distribution of R$129.8 million, representing 20% of the company's R$648.9 million consolidated net income for 2024.
The dividend per share is set at R$1.348923, payable in U.S. dollars on April 4, 2025, to shareholders of record as of March 26, 2025. The payment will be converted using the Brazilian Central Bank's exchange rate of R$/USD 5.8131 published on March 13, 2025.
CFO Luis Blanco emphasized that this distribution demonstrates the company's commitment to shareholder value while maintaining their growth guidance.
Afya (Nasdaq: AFYA; B3: A2FY34) has entered into a share purchase agreement to acquire 100% of Faculdade Única de Contagem (FUNIC) through its subsidiary Afya Participações S.A. The acquisition adds 60 medical school seats in Contagem, Minas Gerais, marking Afya's fifth medical school in the state. The total purchase price is R$ 100 million, with R$ 60 million paid in cash at closing and R$ 40 million in three annual CDI-adjusted installments.
The deal includes potential for 60 additional seats if approved by MEC within 36 months, with R$ 1 million payment per granted seat. At full maturity in 2030, Afya expects an EV/EBITDA of 3.3x with projected Net Revenues of R$ 52.4 million from Medicine operations.
Afya reported strong financial results for Q3 2024, with net revenue increasing 16.3% YoY to R$841.2 million. The company's Adjusted EBITDA grew 25.0% YoY to R$347.9 million, with margin expansion of 290 bps to 41.4%. Net Income rose 26.4% YoY to R$124.1 million. For the nine-month period, net revenue increased 14.4% to R$2,455.3 million, while Adjusted EBITDA grew 24.3% to R$1,089.6 million. The company completed the acquisition of Unidom, adding 300 medical seats, and received authorization for 80 additional seats at UNIMA and 10 seats at Unigranrio, bringing total approved seats to 3,593.